Control of Prostate Cancer Spheroid Growth Using (213)Bi-labeled Multiple Targeted Alpha Radioimmunoconjugates
Micrometastasis is a major problem for prostate cancer CaP patients. Our study investigated the therapeutic potential of multiple targeted alpha-therapy (MTAT) in the treatment pf CaP micrometastases (spheroids) using 213Bi-labeled multiple targeted
radioimmunoconjugates.
WANG J.;
RIZVI S.M.A.;
MADIGAN C.;
COZZI P.J.;
POWER C.A.;
QU C.F.;
MORGENSTERN Alfred;
APOSTOLIDIS Christos;
RUSSEL P.J.;
ALLEN B.J.;
LI Y.;
2006-11-03
WILEY-LISS, INC
JRC35134
Additional supporting files
| File name | Description | File type | |
|---|
